Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-030405
Filing Date
2025-03-03
Accepted
2025-03-03 07:55:46
Documents
113
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rptx-20241231.htm   iXBRL 10-K 3970173
2 EX-4.2 rptx-ex4_2.htm EX-4.2 124333
3 EX-19.1 rptx-ex19_1.htm EX-19.1 106737
4 EX-23.1 rptx-ex23_1.htm EX-23.1 5763
5 EX-31.1 rptx-ex31_1.htm EX-31.1 18099
6 EX-31.2 rptx-ex31_2.htm EX-31.2 16796
7 EX-32.1 rptx-ex32_1.htm EX-32.1 18843
8 GRAPHIC img194168170_0.jpg GRAPHIC 54552
  Complete submission text file 0000950170-25-030405.txt   15875130

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rptx-20241231.xsd EX-101.SCH 1866450
116 EXTRACTED XBRL INSTANCE DOCUMENT rptx-20241231_htm.xml XML 3070587
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39335 | Film No.: 25693818
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)